- Report
- October 2024
- 180 Pages
Global
From €3371EUR$3,545USD£2,834GBP
€3745EUR$3,939USD£3,149GBP
- Report
- March 2025
- 174 Pages
Global
From €5182EUR$5,450USD£4,357GBP
The Hemoglobinopathy Testing market is a subset of the Coagulation and Hemostasis Testing market. It is used to detect and diagnose genetic disorders of hemoglobin, such as sickle cell anemia, thalassemia, and other hemoglobinopathies. Hemoglobinopathy Testing is used to identify carriers of these disorders, as well as to diagnose and monitor patients with hemoglobinopathies. Tests used in Hemoglobinopathy Testing include hemoglobin electrophoresis, high-performance liquid chromatography (HPLC), and DNA-based tests.
Hemoglobinopathy Testing is used in clinical settings, such as hospitals, laboratories, and clinics, as well as in research settings. It is used to diagnose and monitor patients with hemoglobinopathies, as well as to identify carriers of these disorders.
Companies in the Hemoglobinopathy Testing market include Siemens Healthineers, Abbott Laboratories, Ortho Clinical Diagnostics, Bio-Rad Laboratories, and Roche Diagnostics. Show Less Read more